30050BAH4

Evolent Health, Inc.

Could not find a ticker for this position, may be a filing error

A healthcare services company that helps health plans, providers, and hospitals manage complex, high-cost conditions like cancer, heart disease, and musculoskeletal care. It uses its Identifi technology platform and clinical programs to help organizations move from simply billing per visit to "value-based care" that rewards better outcomes. Evolent was founded in 2011 as a joint venture between UPMC and The Advisory Board Company, based in Arlington, Virginia. Its name blends "evolution" and "benevolent," chosen to signal a kinder, transforming approach to healthcare.

CONVERTIBLEUnderlying: EVHCUSIP: 30050BAH4HealthcareUS1 derivative reporter

3.5% Convertible Senior Notes due 2029

Ownership Activity Financials Filings

Insiders

Ranked by how much each holding moved in the last 6 months

Insider

Blackley SethChief Executive Officer, Director · 4 transactions

837.0K+0.9%

Granted 58.9K

McCarthy Daniel JosephPRESIDENT · 4 transactions

423.0K-2.5%

Granted 39.3K

Weinberg JonathanGeneral Counsel · 4 transactions

244.5K-3.8%

Granted 4.9K

Grua Peter JDirector · 1 transaction

123.7K+49.7%

Granted 41.1K

Jelinek Richard MDirector · 1 transaction

107.5K+61.9%

Granted 41.1K

Keck KimDirector · 1 transaction

102.6K+66.8%

Granted 41.1K

Springstubb Brendan BDirector · 1 transaction

99.9K+69.9%

Granted 41.1K

Barbarosh Craig A.Director · 1 transaction

95.0K+76.2%

Granted 41.1K

Glass Russell MonroeDirector · 1 transaction

83.4K+97.2%

Granted 41.1K

Ajayi ToyinDirector · 1 transaction

75.2K+120.6%

Granted 41.1K

Shams AammaadChief Accounting Officer · 4 transactions

66.8K-8.3%

Granted 1.7K

Smith Jill D.Director · 1 transaction

64.2K+177.6%

Granted 41.1K

Guertin Shawn MDirector · 1 transaction

63.1K+187%

Granted 41.1K

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Blackley SethChief Executive Officer, Director · 4 transactions	+0.9%	837.0K	58.9K	—	—
McCarthy Daniel JosephPRESIDENT · 4 transactions	-2.5%	423.0K	39.3K	—	—
Weinberg JonathanGeneral Counsel · 4 transactions	-3.8%	244.5K	4.9K	—	—
Grua Peter JDirector · 1 transaction	+49.7%	123.7K	41.1K	—	—
Jelinek Richard MDirector · 1 transaction	+61.9%	107.5K	41.1K	—	—
Keck KimDirector · 1 transaction	+66.8%	102.6K	41.1K	—	—
Springstubb Brendan BDirector · 1 transaction	+69.9%	99.9K	41.1K	—	—
Barbarosh Craig A.Director · 1 transaction	+76.2%	95.0K	41.1K	—	—
Glass Russell MonroeDirector · 1 transaction	+97.2%	83.4K	41.1K	—	—
Ajayi ToyinDirector · 1 transaction	+120.6%	75.2K	41.1K	—	—
Shams AammaadChief Accounting Officer · 4 transactions	-8.3%	66.8K	1.7K	—	—
Smith Jill D.Director · 1 transaction	+177.6%	64.2K	41.1K	—	—
Guertin Shawn MDirector · 1 transaction	+187%	63.1K	41.1K	—	—

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.